封面
市场调查报告书
商品编码
1544780

谷胱甘肽市场、机会、成长动力、产业趋势分析与预测,2024-2032

Glutathione Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于人们对谷胱甘肽的健康益处,特别是其抗氧化特性的认识不断提高,谷胱甘肽市场预计在 2024 年至 2032 年期间复合年增长率为 7.1%。它以其解毒特性和免疫支持而闻名。消费者对膳食补充剂的偏好以及向预防性医疗保健的转变增强了对谷胱甘肽产品的兴趣。例如,2024 年 4 月,印度着名植物性营养保健品牌 OZiva 推出了「Bioactive Gluta」碳酸饮料,以解决印度普遍存在的皮肤问题,并利用对谷胱甘肽不断增长的需求。该产品旨在利用谷胱甘肽的抗氧化特性来对抗色素沉着并增强皮肤光泽。药物和营养保健品配方的创新正在提高这些补充剂的可用性和功效,从而推动市场扩张。

随着年龄的增长,天然谷胱甘肽水平下降,人们对维持健康和应对年龄相关问题的补充剂的兴趣日益浓厚。这种人口结构的变化与个人化营养的趋势一致,即消费者寻求适合其健康需求的产品。研究和临床试验一致强调谷胱甘肽在治疗慢性疾病和皮肤病方面的益处,扩大了其市场吸引力。

整个谷胱甘肽市场根据产品、应用和地区进行细分。

氧化谷胱甘肽 (GSSG) 部分由于其在细胞氧化还原调节中的关键作用及其在医疗和美容领域的应用而获得了巨大的关注。 GSSG 对于维持体内氧化压力和抗氧化防御之间的平衡至关重要。它在各个治疗领域的重要性,包括其在治疗神经退化性疾病和改善代谢健康方面的潜力,正在推动需求。此外,在化妆品中,GSSG 因其在亮肤和抗衰老疗法中的作用而受到重视。人们对先进护肤解决方案和个人化医疗的兴趣日益浓厚,推动了该细分市场的成长。

营养保健品的应用将对 2024-2032 年的市场成长产生正面影响。随着对膳食补充剂的需求不断上升,以其抗氧化特性和健康益处而闻名的谷胱甘肽正在被纳入营养保健品配方中。它在支持排毒、免疫功能和整体健康方面的多功能性使其成为营养保健产品中的宝贵成分。预防性保健和个人化营养的不断增长趋势有利于将产品融入保健补充剂和功能性食品中。营养保健品应用的持续创新将进一步扩大谷胱甘肽的潜力,增加市场价值。

在整个地区健康意识不断增强和可支配收入不断增加的推动下,亚太地区谷胱甘肽市场预计到 2032 年将呈现强劲增长。不断壮大的中产阶级,加上人们对预防性医疗保健和健康日益增长的兴趣,正在推动市场扩张。此外,中国、印度和日本蓬勃发展的製药和化妆品产业也导致对谷胱甘肽产品的需求增加。为各种应用开发产品特性的持续研发努力将塑造未来几年的区域市场前景。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
    • 价值链
    • 主要製造商
    • 前往市场路线
    • 主要经销商
      • 新的分销管道
    • 全行业利润率
  • 产业影响力
    • 成长动力
    • 市场挑战
    • 市场机会
      • 新市场/新应用
      • 成长潜力分析
  • 原料景观
    • 製造趋势
      • 技术演进
      • 永续製造
        • 绿色实践
        • 脱碳
    • 新原料
    • 原物料价格走势(美元/吨)
      • 我们
      • 欧洲联盟
      • 英国
      • 中国
      • 东南亚
      • 海湾合作委员会
  • 法规和市场影响
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场规模与预测:按产品划分,2021-2032 年

  • 主要趋势
  • 谷胱甘肽减少
  • 氧化谷胱甘肽

第 6 章:市场规模与预测:按应用划分,2021-2032 年

  • 主要趋势
  • 製药
  • 化妆品
  • 营养保健品
  • 食物

第 7 章:市场规模与预测:按地区划分,2021-2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • MEA
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • MEA 的其余部分

第 8 章:公司简介

  • Anhui GSH Bio-Technology Co., LTD
  • Cayman Chemical Company
  • Haihang Industry Co., Ltd.
  • Herbo Nutra
  • Kaiping Genuine Biochemical Pharmaceutical Co., Ltd
  • KOHJIN Life Sciences Co., Ltd.
  • Kyowa Hakko Bio Co., Ltd.,
  • Meteoric Biopharmaceuticals Pvt. Ltd.
  • Shandong Jincheng Biological Pharmaceutical Co., Ltd.
  • Xi'an Fengzu Biological Technology Co., Ltd
  • YAOPHARMA
简介目录
Product Code: 4147

The glutathione market is anticipated to register a 7.1% CAGR over 2024-2032, owing to heightened awareness of glutathione's health benefits, particularly its antioxidant properties. It is known for its detoxifying properties and immune support. The consumer inclination for dietary supplements and the shift towards preventive healthcare amplify interest in glutathione products. For instance, in April 2024, OZiva, a prominent Indian plant-based nutraceutical brand, introduced 'Bioactive Gluta' fizzy drink, to address prevalent skin issues in India and capitalize on the surging demand for glutathione. The product aims to combat pigmentation and enhance skin radiance using the antioxidative properties of glutathione. Innovations in pharmaceutical and nutraceutical formulations are enhancing the availability and efficacy of these supplements, thus propelling market expansion.

As people age, natural glutathione levels decline, increasing interest in supplements to maintain health and counter age-related issues. This demographic shift aligns with the trend in personalized nutrition, where consumers seek products tailored to their health needs. Research and clinical trials consistently highlight glutathione's benefits in managing chronic diseases and skin disorders, broadening its market appeal.

The overall glutathione market is segmented based on product, application, and region.

The glutathione oxidized (GSSG) segment is gaining significant traction due to its crucial role in cellular redox regulation and its applications in both medical and cosmetic fields. GSSG is essential for maintaining the balance between oxidative stress and antioxidant defense in the body. Its importance in various therapeutic areas, including its potential in treating neurodegenerative diseases and improving metabolic health, is driving demand. Additionally, in cosmetics, GSSG is valued for its role in skin brightening and anti-aging treatments. The rising interest in advanced skincare solutions and personalized medicine is contributing to the segment growth.

The nutraceutical application will positively influence the market growth over 2024-2032. As the demand for dietary supplements continues to rise, glutathione, renowned for its antioxidant properties and health benefits, is being incorporated into nutraceutical formulations. Its versatility in supporting detoxification, immune function, and overall wellness makes it a valuable ingredient in nutraceutical products. The rising trend of preventive healthcare and personalized nutrition is favoring product integration into health supplements and functional foods. The continued innovation in nutraceutical applications will further widen the potential of glutathione, adding to market value.

Asia Pacific glutathione market is estimated to display robust growth through 2032, driven by increasing health awareness and rising disposable incomes across the region. The expanding middle class, coupled with a growing interest in preventive healthcare and wellness, is fueling market expansion. Additionally, the burgeoning pharmaceutical and cosmetic industries in China, India, and Japan are contributing to the heightened demand for glutathione products. The constant R and D efforts to exploit the product properties for various applications will shape the regional market outlook in the coming years.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Base estimates and calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Value chain
    • 3.1.2 Key manufacturers
    • 3.1.3 Go to market routes
    • 3.1.4 Key distributors
      • 3.1.4.1 New distribution channels
    • 3.1.5 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Market challenges
    • 3.2.3 Market opportunities
      • 3.2.3.1 New markets/applications
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
      • 3.3.1.1 Technology evolution
      • 3.3.1.2 Sustainable manufacturing
        • 3.3.1.2.1 Green practices
        • 3.3.1.2.2 Decarbonization
    • 3.3.2 New raw materials
    • 3.3.3 Raw material pricing trends (USD/Ton)
      • 3.3.3.1 U.S.
      • 3.3.3.2 European Union
      • 3.3.3.3 UK
      • 3.3.3.4 China
      • 3.3.3.5 Southeast Asia
      • 3.3.3.6 GCC
  • 3.4 Regulations and market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Product, 2021-2032 (USD Billion, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Glutathione reduced
  • 5.3 Glutathione oxidized

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Billion, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Pharmaceutical
  • 6.3 Cosmetics
  • 6.4 Nutraceutical
  • 6.5 Food

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Billion, Kilo Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 Anhui GSH Bio-Technology Co., LTD
  • 8.2 Cayman Chemical Company
  • 8.3 Haihang Industry Co., Ltd.
  • 8.4 Herbo Nutra
  • 8.5 Kaiping Genuine Biochemical Pharmaceutical Co., Ltd
  • 8.6 KOHJIN Life Sciences Co., Ltd.
  • 8.7 Kyowa Hakko Bio Co., Ltd.,
  • 8.8 Meteoric Biopharmaceuticals Pvt. Ltd.
  • 8.9 Shandong Jincheng Biological Pharmaceutical Co., Ltd.
  • 8.10 Xi'an Fengzu Biological Technology Co., Ltd
  • 8.11 YAOPHARMA